You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

118 Results
Guidelines and Advice
Status: Current
ID: GL-C50-31
Mar 2017
Guidelines and Advice
Status: Current
ID: GL-1-A-2016-2
Oct 2017
Guidelines and Advice
Status: Archived
ID: 18-4
Sep 2017
Guidelines and Advice
Status: Current
ID: GL-END MOTAC 5
Aug 2017
Guidelines and Advice
Status: Current
Jun 2017
Drug
Other Name(s): Uromitexan® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Nov 2017
Drug
Other Name(s): Oncovin® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Nov 2017
Drug
Other Name(s): Zoladex® (AstraZeneca) , Zoladex® LA (AstraZeneca)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Mar 2016
Drug
Other Name(s): Onivyde® (Baxalta Canada)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Sep 2017
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Palliative
Drugs Used:
CISplatin,
fluorouracil
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2017
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
etoposide,
leucovorin,
fluorouracil
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2017
Regimen
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
  • goserelin
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
goserelin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2016

Pages